3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Healthy Participants
5
Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Prostatic Neoplasms
2
Healthy Volunteers
2
Breast Neoplasms
2
cMET-dysregulated Advanced Solid Tumors
1
Venous Thrombosis
1
Venous Thromboembolism
1
Solid Tumor, Adult
1
Rectal Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Liver Cirrhosis
1
Hypoalphalipoproteinemias
1
Healthy Adult Participants
1
Healthy
1
Endometrial Neoplasms
1
Drug-drug Interaction,SHR3680
1
Colorectal Neoplasms
1
Chronic Cough
1
Carcinoma, Squamous Cell
1
Advanced Solid Tumor
1
Advanced Non-small Cell Lung Cancer
1
Interventions
apixaban
11
Dalteparin
10
Rivaroxaban
7
Enoxaparin
5
Fondaparinux
4
Tinzaparin
3
Heparin, Low-Molecular-Weight
3
Aspirin
3
edoxaban
2
Warfarin
2
Observation
2
Dabigatran
2
sotorasib
1
calcium heparin
1
betrixaban
1
bemiparin
1
argatroban
1
Tacrolimus
1
Tablets
1
Simvastatin
1
Rosuvastatin Calcium
1
Nadroparin
1
Heparin
1
Gemcitabine
1
Drug Therapy
1
Data Collection
1
Cyclosporine
1
AVE 5026
1
ALT-836
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Venous Thromboembolism
×
Rosuvastatin Calcium
×
Clear all
NCT01524653
2018-07-10
DISOLVE
University of Vermont
Phase 2
Completed
38 enrolled